Safety and Immunogenicity of Three Influenza Vaccines Adults Ages 18 and Older
Clinical trial NCT01992094 · COMPLETED
Trial details
- NCT number
- NCT01992094
- Sponsor
- Novartis Vaccines
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2014-07-01
- Enrollment
- 2680
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.